What is the recommended treatment for small intestinal bacterial overgrowth (SIBO)?

Treatment for SIBO

Rifaximin 550 mg twice daily for 1-2 weeks is the first-line antibiotic treatment for SIBO, achieving symptom resolution in approximately 60-80% of patients with proven disease. 1

Diagnostic Approach Before Treatment

The most recent 2025 British Society of Gastroenterology guidance emphasizes testing rather than empirical treatment whenever possible to establish the diagnosis and support antibiotic stewardship 1. This represents an important shift from previous recommendations that favored empirical therapy.

Diagnostic Testing Options:

• Breath testing: Hydrogen combined with methane analysis is more accurate than hydrogen alone 1
• Small bowel aspirate: Qualitative assessment is easier than quantitative culture and should be coordinated with local microbiology services beforehand 1
• Empirical treatment: Only consider when testing is unavailable or in patients with high pretest probability (anatomical abnormalities, prior small bowel surgery, pseudo-obstruction, diverticulosis) 2

First-Line Antibiotic Treatment

Rifaximin is preferred because it is non-absorbed from the GI tract, reducing systemic resistance risk 1. The dosing is:

• 550 mg twice daily for 1-2 weeks 1
• Effective in 60-80% of proven SIBO cases 1

Alternative Antibiotics (Equally Effective):

When rifaximin is unavailable or ineffective, use 1, 3:

• Doxycycline (tetracycline class)
• Ciprofloxacin (caution: long-term use causes tendonitis/rupture risk; use lowest effective dose) 3
• Amoxicillin-clavulanic acid
• Cefoxitin (cephalosporin)
• Metronidazole/tinidazole (less effective; if used long-term, warn patients to stop immediately if numbness/tingling develops—early sign of reversible peripheral neuropathy) 3

Metronidazole is explicitly less effective and should not be first choice 1.

Treatment Duration Based on Underlying Cause

Reversible SIBO (e.g., during chemotherapy, temporary immunosuppression):

• One course of antibiotics is typically sufficient 1

Recurrent SIBO (structural abnormalities, chronic dysmotility):

Multiple approaches are used 1, 3:

• Cyclical antibiotics: Rotating different antibiotics every 2-6 weeks (sometimes with 1-2 week antibiotic-free periods between cycles)
• Low-dose long-term antibiotics
• Recurrent short courses as needed

The rotation strategy helps prevent resistant organisms, including Clostridioides difficile 3.

Refractory SIBO

For patients not responding to standard antibiotics 3:

• Octreotide: Reduces secretions and slows GI motility; has been used in refractory cases
• Consider whether SIBO is truly present or if other overlapping conditions exist (bile salt malabsorption, pancreatic insufficiency, celiac disease) 1

Adjunctive Treatments

Probiotics:

• No current data support routine use in SIBO treatment 3
• May have a role in prevention or as adjunct, but evidence is lacking

Dietary Modifications:

• Low FODMAP diet: May complement antibiotic therapy but should not be used in malnourished patients 3
• Reduce fiber to decrease bacterial fermentation and gas production 3

Prokinetics:

• May help in patients with underlying dysmotility to prevent recurrence, though specific evidence for SIBO is limited

Important Clinical Pitfalls

1. Pancreatic enzyme replacement therapy (PERT) intolerance: If patients cannot tolerate PERT, this often indicates underlying SIBO. Once SIBO is eradicated, PERT is typically tolerated 1

2. Multiple overlapping diagnoses: In cancer patients and those with complex GI conditions, SIBO often coexists with bile salt malabsorption, pancreatic insufficiency, or other disorders. Lack of response to antibiotics may indicate:

   • Resistant organisms
   • SIBO not actually present
   • Other concurrent disorders causing similar symptoms 1

3. Antibiotic resistance: The risk of resistant organisms, including C. difficile, must be considered with repeated or long-term antibiotic use 3

4. Long-term antibiotic toxicity:

   • Metronidazole: Peripheral neuropathy (reversible if caught early)
   • Ciprofloxacin: Tendonitis and tendon rupture
   • Both require lowest effective doses and patient vigilance 3

Treatment Algorithm

1. Confirm diagnosis with breath testing (hydrogen + methane) or small bowel aspirate when possible
2. First-line: Rifaximin 550 mg twice daily for 1-2 weeks
3. If rifaximin unavailable: Use doxycycline, ciprofloxacin, or amoxicillin-clavulanic acid
4. Assess response at 2-4 weeks
5. If symptoms recur:
   • For reversible causes: Repeat single course
   • For chronic/structural causes: Institute cyclical or rotating antibiotic regimen
6. If refractory: Consider octreotide or reassess for alternative/concurrent diagnoses
7. Address underlying causes: Treat dysmotility, optimize nutrition, manage concurrent conditions